Navigation Links
CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
Date:10/22/2013

; It selectively targets 5-HT1F receptors expressed in the trigeminal pathway.  Its novel chemical class and differentiated site and mechanism of action led to Lasmiditan's designation as a "ditan", a new drug class, by the INN.

CoLucid has successfully completed six clinical studies for Lasmiditan, including a Phase 2b study treating a single migraine attack in 391 patients, as well as a TQTc study.

Phase 3 development will address two major unmet needs in patients who are poorly served by currently available therapies:

  • Patients with risk factors for cardiovascular disease and those with cardiovascular disease
  • Patients who have not had adequate response to triptans

ABOUT MIGRAINE

Migraine is ranked as the seventh highest cause of global disability and in the top 10 causes of disability in 14 of 21 world regions studied, according to findings by the Global Burden of Disease Survey 2010 conducted by the World Health Organization. It is the leading cause of disability among neurological disorders.  Some 36 million Americans have migraine, more than have asthma or diabetes combined.  Migraine can be extremely disabling and costly, accounting for more than $20 billion in direct (e.g. doctor visits, medications) and indirect (e.g. missed work, lost productivity) expenses each year in the United States. The prevalence of migraine in Asia is approximately 9%, and in South Korea alone, it is 6%.  According to statistics available from the Health and Insurance Review Agency (HIRA), in 2012 more than 500,000 patients were diagnosed with migraine in Korea, with women accounting for 72% of these numbers.

ABOUT COLUCID PHARMACEUTICALS, INC.

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc; ILDONG Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  El Camino Hospital, a leader ... is utilizing the Leaf Patient Monitoring system to help ... movement of patients susceptible to bed sores. ... 138-patient study of the system, which showed dramatic improvement ... patients regularly is the one of the most effect ...
(Date:7/30/2014)... , July 30, 2014  InnoPharma, Inc. today announced ... (the generic equivalent of Zyprexa® injection), in Canada.  Olanzapine ... disturbed behaviors in patients with schizophrenia or bipolar I ... injectable drug, InnoPharma has entered into an agreement with ... will make, use, sell, market and distribute Olanzapine ...
(Date:7/30/2014)... Cynosure, Inc. (NASDAQ: CYNO ... non-invasive and minimally invasive applications, today announced that the Board ... and Chief Financial Officer Timothy W. Baker to ... will continue to serve as CFO and will take the ... Chairman and Chief Executive Officer. "Tim has ...
Breaking Medicine Technology:El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2
... Streamline Health Solutions, Inc. (Nasdaq: STRM ... for hospitals, announced today that two of its clients, ... North Carolina, contracted with Streamline Health to implement new ... began the beta phase of integration earlier this year, ...
... July 28, 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: ... financial results for the company,s second quarter ended June 30, ... Aug. 11, 2011. The Pacira management team will host a ... and upcoming developments on Thursday, Aug. 11, 2011 at 9 ...
Cached Medicine Technology:Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 2Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 3Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 4Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call 2
(Date:7/30/2014)... (PRWEB) July 30, 2014 The ... with the Penn's Abramson Cancer Center, will host a ... together area experts in the field of mesothelioma. September ... The conference is open to the public, and specifically ... and those who have been exposed to asbestos. , ...
(Date:7/30/2014)... 2014 WalkingSticksandCane.com has just received ... ladies will love the new European fashions and the men ... sticks and canes are from one from one of the ... the styles re unique and offer the consumer the ability ... Walking Sticks are some of the rarest and most sought ...
(Date:7/30/2014)... 30, 2014 Recently, the Kansas ... period, waiving start-up fees for hospitals and clinics ... 2014 until September 30, 2014. , Modern healthcare ... and increased complexity of digital patient information, often ... applications, and data silos. , Traditional health IT ...
(Date:7/30/2014)... The Restore My Blood Sugar review recently published ... levels can now find an amazingly successful method of reducing ... created by D. Chao and Andrew Forester who claim that ... it comes to normalizing blood sugar levels. Chao actually is ... to the cure of diabetes that all patients should find ...
(Date:7/30/2014)... Land, TX (PRWEB) July 30, 2014 New ... recently announced their plans to move to a new facility. ... announced, but they will be moving soon. , MedX Pharmacy ... W Broadway in Pearland, TX 77581. This is the old ... their current one and will include a drive thru for ...
Breaking Medicine News(10 mins):Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3Health News:European Walking Sticks from WalkingSticksandCane.com 2Health News:Kansas Health Image Exchange Announces Open Enrollment; Virtual CD from Offsite Image Solves Problems with Unreadable Patient Images, Delayed Diagnosis 2Health News:Kansas Health Image Exchange Announces Open Enrollment; Virtual CD from Offsite Image Solves Problems with Unreadable Patient Images, Delayed Diagnosis 3Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:MedX Pharmacy Relocates to New Facility 2
... , HERNDON, Va., Dec. ... it has filed an Investigational New Drug (IND) application with the ... progesterone infusion product. , In September of this year, the company ... ( www.synapse-trial.com ) in early 2010 to evaluate the safety and ...
... , CINCINNATI and JACKSONVILLE, Fla., Dec. 8 LCA-Vision ... correction services under the Lasik Plus ® brand, announced today that ... free Lasik Plus® corrective vision surgery to U.S. military veterans ... Warrior Project, and is doing its part to enhance the lives ...
... DIEGO, Dec. 8 PROVERI, Inc. is pleased to ... annual New England Venture Summit Top Innovator award by youngStartup Ventures. ... a leading role in innovation for the Technology, Life Sciences and ... President and Chief Executive Officer of PROVERI, Inc., will present the ...
... , ANN ARBOR, Mich., Dec. 8 Accuri Cytometers ... systems, today announced the 2009 recipients of its Accuri Flow ... Flow Cytometer® System each year to two sets of researchers, ... innovative uses of flow cytometry. Explicitly designed for routine ...
... ... challenges in both structural reform and unavailability of resources as the ... ,non-working, age. This calls for the introduction of new schemes in ... the growing ageing population. The involvement of Information and Communication Technology ...
... ... Cavendish Street, the UK’s premier centre for Integrated Medicine, launches Regenerus, the most comprehensive ... ... the UK Health Secretary, Andy Burnham, published the results of a Department of Health ...
Cached Medicine News:Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2Health News:PROVERI, Inc. Named a Top Innovator Winner 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: